Background More than half of patients with multiple sclerosis have progressive disease
characterised by accumulating disability. The absence of treatments for progressive multiple …

Neurodegenerative diseases are still a challenge for researchers and clinicians due to its
complexity. Traditional medicines usually do not provide sufficient protection against these …

Due to the limitations of pharmacological and other current therapeutic strategies, stem cell
therapies have emerged as promising options for treating many incurable neurologic …

Preclinical and clinical studies with various stem cells, their secretomes, and extracellular
vesicles (EVs) indicate their use as a promising strategy for the treatment of various …

Introduction: Several studies indicate the role of mesenchymal stem cells (MSCs) as an
important tool in regenerative medicine associated with injuries that affect the central …

Neurological disease encompasses a diverse group of disorders of the central and
peripheral nervous systems, which collectively are the leading cause of disease burden …

Mesenchymal stem cells (MSCs) are stromal cells that have the ability to self‐renew and
also exhibit multilineage differentiation into both mesenchymal and nonmesenchymal …

Rapid developments in stem cell research in recent years have provided a solid foundation
for their use in medicine. Over the last few years, hundreds of clinical trials have been …

Multiple sclerosis (MS), a complex disorder of the central nervous system (CNS), is
characterized with axonal loss underlying long-term progressive disability. Currently …

Human mesenchymal stem cells (hMSCs) have tremendous promise for use in a variety of
clinical applications. The ability of these cells to self-renew and differentiate into multiple …